Dermatology

Dermatology

Scratching the surface of eczema care in the UKScratching the surface of eczema care in the UK
Scratching the surface of eczema care in the UK

Pharmafilespeaks to Allergy UK: Allergy UK explores the future of eczema diagnosis, treatment, and support

Dec 1, 2021 Dermatology
Dermatologically speaking: Finding new treatments for womenDermatologically speaking: Finding new treatments for women
Dermatologically speaking: Finding new treatments for women

Organon discusses the ways in which women's skin conditions can be managed

Dec 1, 2021 Dermatology
Insight and oversight: Making the most of virtual platforms in dermatologyInsight and oversight: Making the most of virtual platforms in dermatology
Insight and oversight: Making the most of virtual platforms in dermatology

FIDE discuss the need for communication between patients and their HCPs, specifically with virtual platforms in mind, and how this can improve dermatology care

Dec 1, 2021 Dermatology
“The pain keeps me awake at night. I can’t cope with this anymore”“The pain keeps me awake at night. I can’t cope with this anymore”
“The pain keeps me awake at night. I can’t cope with this anymore”

There have been significant advances in dermatological care, this article explores this as well as looking forward to what still needs to be done

Dec 1, 2021 Dermatology
Supporting dermatology and oncology services to build back better post-COVID-19Supporting dermatology and oncology services to build back better post-COVID-19
Supporting dermatology and oncology services to build back better post-COVID-19

The COVID-19 pandemic has been challenging service-wide for the NHS, but the pharma industry can support patients and the NHS going forward

Dec 1, 2021 Dermatology
‘Cumulative life course impairment’: The unforeseen burdens of severe eczema‘Cumulative life course impairment’: The unforeseen burdens of severe eczema
‘Cumulative life course impairment’: The unforeseen burdens of severe eczema

Skin diseases have many impacts on patients' lives, AbbVie explores these impacts

Dec 1, 2021 Dermatology